Form 4: Stoke Therapeutics Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Barry Ticho, CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc., sold 4,767 shares of common stock on August 14, 2026.

Summary

  • Option exercise/conversion: acquired 10,000 Common Stock on August 14, 2026; holds 30,422 after (Direct).
  • Open-market sale: disposed of 4,525 Common Stock at $32.01 ($144,833) on August 18, 2026; holds 25,897 after (Direct).
  • Open-market sale: disposed of 242 Common Stock at $32.47 ($7,857) on August 18, 2026; holds 25,655 after (Direct).
  • Option exercise/conversion: disposed of 10,000 Performance Stock Units on August 14, 2026 (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $152,690 of stock on the open market.

Insider Transactions

Barry Ticho — Officer (CHIEF MEDICAL OFFICER)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-14Option exercise/conversionCommon Stock10,000——30,422
2026-08-18Open-market saleCommon Stock4,525$32$144.8K25,897
2026-08-18Open-market saleCommon Stock242$32$7.9K25,655
2026-08-14Option exercise/conversionPerformance Stock Units10,000——0

Key Dates

DateDescription
2026-08-14Option exercise/conversion (10,000 shares)
2026-08-18Open-market sale (4,525 shares)
2026-08-18Open-market sale (242 shares)
2026-08-14Option exercise/conversion (10,000 shares)

Keywords

insider transaction, Form 4, STOK, Stoke Therapeutics, Inc., bearish, Barry Ticho

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.